Preventive Effect of Pretreatment with Intravenous Nicorandil on Contrast-Induced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Angiography (PRINCIPLE Study)
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: To investigate the effect of pretreatment with intravenous nicorandil on the incidence of contrast-induced nephropathy (CIN) in patients with renal dysfunction undergoing coronary angiography. Materials and Methods: This randomized controlled multicenter study enrolled a total of 166 patients (nicorandil n=81; control n=85) with an estimated glomerular filtration rate <60 mL/min. Nicorandil 12 mg dissolved in 100 mL of 0.9% saline was administered intravenously for 30 minutes just prior to coronary angiography in the nicorandil group. The same volume of only saline was given to the control group. The primary endpoint was the incidence of CIN, defined as >0.5 mg/dL increase or >25% rise in serum creatinine (SCr) concentration within 48 hours of contrast exposure compared to baseline. Results: The final analysis included 149 patients (nicorandil n=73; control n=76). The baseline characteristics and the total volume of the used contrast (Iodixanol, 125.6±69.1 mL vs. 126.9±74.6 mL, p=0.916) were similar between the two groups. The incidence of CIN also did not differ between the nicorandil and control groups (6.8% vs. 6.6%, p=0.794). There was no difference between the two groups in the relative change in SCr from baseline to peak level within 48 hours after coronary angiography (-1.58±24.07% vs. 0.96±17.49%, p=0.464), although the nicorandil group showed less absolute change in SCr than the control group (-0.01±0.43 mg/mL vs. 0.02±0.31 mg/mL, p=0.005). Conclusion:Prophylactic intravenous infusion of nicorandil did not decrease the incidence of CIN in patients with renal dysfunction undergoing coronary angiography.
Abstract
Purpose: To investigate the effect of pretreatment with intravenous nicorandil on the incidence of contrast-induced nephropathy (CIN) in patients with renal dysfunction undergoing coronary angiography. Materials and Methods: This randomized controlled multicenter study enrolled a total of 166 patients (nicorandil n=81; control n=85) with an estimated glomerular filtration rate <60 mL/min. Nicorandil 12 mg dissolved in 100 mL of 0.9% saline was administered intravenously for 30 minutes just prior to coronary angiography in the nicorandil group. The same volume of only saline was given to the control group. The primary endpoint was the incidence of CIN, defined as >0.5 mg/dL increase or >25% rise in serum creatinine (SCr) concentration within 48 hours of contrast exposure compared to baseline. Results: The final analysis included 149 patients (nicorandil n=73; control n=76). The baseline characteristics and the total volume of the used contrast (Iodixanol, 125.6±69.1 mL vs. 126.9±74.6 mL, p=0.916) were similar between the two groups. The incidence of CIN also did not differ between the nicorandil and control groups (6.8% vs. 6.6%, p=0.794). There was no difference between the two groups in the relative change in SCr from baseline to peak level within 48 hours after coronary angiography (-1.58±24.07% vs. 0.96±17.49%, p=0.464), although the nicorandil group showed less absolute change in SCr than the control group (-0.01±0.43 mg/mL vs. 0.02±0.31 mg/mL, p=0.005). Conclusion:Prophylactic intravenous infusion of nicorandil did not decrease the incidence of CIN in patients with renal dysfunction undergoing coronary angiography.
참고문헌 (26)
- McCullough PA, "Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality", Am J Med, 103, pp.368~375 (1997)
- Nash K, "Hospital-acquired renal insufficiency", Am J Kidney Dis, 39, pp.930~936 (2002)
- Min Jee Kim, "Impact of Acute Kidney Injury on Clinical Outcomes after ST Elevation Acute Myocardial Infarction", Yonsei Medical Journal, 52(4), pp.603~609 (2011), 연세대학교의과대학
- Rihal CS, "Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention", Circulation, 105, pp.2259~2264 (2002)
- Mehran R, "A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation", J Am Coll Cardiol, 44, pp.1393~1399 (2004)
- Persson PB, "Pathophysiology of contrast medium-induced nephropathy", Kidney Int, 68, pp.14~22 (2005)
- Wong PC, "Pathophysiology of contrast-induced nephropathy", Int J Cardiol, 158, pp.186~192 (2012)
- Taira N, "Nicorandil as a hybrid between nitrates and potassium channel activators", Am J Cardiol, 63, pp.18J~24J (1989)
- Sun Z, "Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide", Am J Physiol Renal Physiol, 294, pp.F491~F498 (2008)
- Dangas G, "Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables", Am J Cardiol, 95, pp.13~19 (2005)
- Brezis M, "Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys", J Clin Invest, 88, pp.390~395 (1991)
- Brenner BM, "Endothelium-dependent vascular responses. Mediators and mechanisms", J Clin Invest, 84, pp.1373~1378 (1989)
- Myers SI, "Iodinated contrast induced renal vasoconstriction is due in part to the downregulation of renal cortical and medullary nitric oxide synthesis", J Vasc Surg, 44, pp.383~391 (2006)
- Fujisaki K, "Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function", Clin Exp Nephrol, 7, pp.279~283 (2003)
- Ellis JH, "Reducing the risk of contrast-induced nephropathy: a perspective on the controversies", AJR Am J Roentgenol, 192, pp.1544~1549 (2009)
- Spargias K, "Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention", Circulation, 120, pp.1793~1799 (2009)
- Onbasili AO, "Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures", Heart, 93, pp.698~702 (2007)
- Quayle JM, "ATP-sensitive and inwardly rectifying potassium channels in smooth muscle", Physiol Rev, 77, pp.1165~1232 (1997)
- Miki T, "Roles of KATP channels as metabolic sensors in acute metabolic changes", J Mol Cell Cardiol, 38, pp.917~925 (2005)
- Sato T, "Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels", J Am Coll Cardiol, 35, pp.514~518 (2000)
- Shimizu S, "Nicorandil ameliorates ischaemia-reperfusion injury in the rat kidney", Br J Pharmacol, 163, pp.272~282 (2011)
- Lee TM, "Effect of nicorandil on proteinuria in well controlled hypertensive patients", J Hypertens, 27, pp.618~625 (2009)
- Ishii H, "Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction", Circulation, 112, pp.1284~1288 (2005)
- Molitoris BA, "Improving outcomes of acute kidney injury: report of an initiative", Nat Clin Pract Nephrol, 3, pp.439~442 (2007)
- Solomon R, "Contrast-induced acute kidney injury", Circulation, 122, pp.2451~2455 (2010)
- Briguori C, "Cystatin C and contrast-induced acute kidney injury", Circulation, 121, pp.2117~2122 (2010)